ERCP for the initial management of malignant biliary obstruction – real world data on 596 procedures

References

• Tsetis D, Krokidis Μ, Negru D, et al. Malignant biliary obstruction: the current role of interventional radiology. Ann Gastroenterol. 2016;29(1):33–36.
   PubMedGoogle Scholar
• Kapoor BS, Mauri G, Lorenz JM. Management of biliary strictures: state-of-the-art review. Radiology. 2018;289(3):590–603. doi: 10.1148/radiol.2018172424.
   PubMed Web of Science ®Google Scholar
• Jarosova J, Macinga P, Hujova A, et al. Endoscopic radiofrequency ablation for malignant biliary obstruction. World J Gastrointest Oncol. 2021;13(10):1383–1396. doi: 10.4251/wjgo.v13.i10.1383.
   PubMed Web of Science ®Google Scholar
• Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261–280. doi: 10.1038/nrgastro.2016.51.
   PubMed Web of Science ®Google Scholar
• Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851–862. doi: 10.1001/jama.2021.13027.
   PubMed Web of Science ®Google Scholar
• Kiriyama S, Kozaka K, Takada T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17–30. doi: 10.1002/jhbp.512.
   PubMed Web of Science ®Google Scholar
• Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–1825. doi: 10.1056/NEJMoa1011923.
   PubMed Web of Science ®Google Scholar
• Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline – updated October 2017. Endoscopy. 2018;50(9):910–930. doi: 10.1055/a-0659-9864.
   PubMed Web of Science ®Google Scholar
• Pereiras RV, Jr., Rheingold OJ, Huston D, et al. Relief of malignant obstructive jaundice by percutaneous insertion of a permanent prosthesis in the biliary tree. Ann Intern Med. 1978;89(5 Pt 1):589–583. doi: 10.7326/0003-4819-89-5-589.
   PubMed Web of Science ®Google Scholar
• Soehendra N, Reynders-Frederix V. Palliative bile duct drainage – a new endoscopic method of introducing a transpapillary drain. Endoscopy. 1980;12(1):8–11. doi: 10.1055/s-2007-1021702.
   PubMed Web of Science ®Google Scholar
• Giovannini M, Moutardier V, Pesenti C, et al. Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy. 2001;33(10):898–900. doi: 10.1055/s-2001-17324.
   PubMed Web of Science ®Google Scholar
• Qumseya BJ, Jamil LH, Elmunzer BJ, et al. ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction. Gastrointest Endosc. 2021;94(2):222–234.e22. doi: 10.1016/j.gie.2020.12.035.
   PubMed Web of Science ®Google Scholar
• Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140(2):170–178.
   PubMedGoogle Scholar
• Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–393. doi: 10.1016/s0016-5107(91)70740-2.
   PubMed Web of Science ®Google Scholar
• Weston BR, Ross WA, Wolff RA, et al. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: How soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer. 2008;112(11):2417–2423. doi: 10.1002/cncr.23454.
   PubMed Web of Science ®Google Scholar
• Asadi H, Hollingsworth R, Pennycooke K, et al. A review of percutaneous transhepatic biliary drainage at a tertiary referral Centre. Clin Radiol. 2016;71(12):1312.e7–e11. doi: 10.1016/j.crad.2016.05.013.
   PubMed Web of Science ®Google Scholar
• Nennstiel S, Weber A, Frick G, et al. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years. J Clin Gastroenterol. 2015;49(9):764–770. doi: 10.1097/MCG.0000000000000275.
   PubMed Web of Science ®Google Scholar
• Lee TH, Moon JH, Stuart S. Role of ERCP in malignant hilar biliary obstruction. Gastrointest Endosc Clin N Am. 2022;32(3):427–453. doi: 10.1016/j.giec.2022.01.003.
   PubMedGoogle Scholar
• Adler DG, Lieb JG, 2nd, Cohen J, et al. Quality indicators for ERCP. Gastrointest Endosc. 2015;81(1):54–66. doi: 10.1016/j.gie.2014.07.056.
   PubMed Web of Science ®Google Scholar
• Domagk D, Oppong KW, Aabakken L, et al. Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. Endoscopy. 2018;50(11):1116–1127. doi: 10.1055/a-0749-8767.
   PubMed Web of Science ®Google Scholar
• Fugazza A, Troncone E, Amato A, et al. Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem? Dig Liver Dis. 2022;54(4):529–536. doi: 10.1016/j.dld.2021.07.010.
   PubMedGoogle Scholar
• Shanmugarajah I, Solhaug M, Aslam O, et al. Efficacy and safety assessment of ERCP in patients with malignant biliary obstruction. Acta Gastroenterol Belg. 2017;80(4):487–491.
   PubMed Web of Science ®Google Scholar
• Keulen AV, Gaspersz MP, van Vugt JLA, et al. Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma. Surgery. 2022;172(6):1606–1613. doi: 10.1016/j.surg.2022.06.028.
   PubMed Web of Science ®Google Scholar
• Coelen RJS, Roos E, Wiggers JK, et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(10):681–690. doi: 10.1016/S2468-1253(18)30234-6.
   PubMed Web of Science ®Google Scholar
• Zhao XQ, Dong JH, Jiang K, et al. Comparison of percutaneous transhepatic biliary drainage and endoscopic biliary drainage in the management of malignant biliary tract obstruction: a meta-analysis. Dig Endosc. 2015;27(1):137–145. doi: 10.1111/den.12320.
   PubMed Web of Science ®Google Scholar
• Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85(5):904–914. doi: 10.1016/j.gie.2016.12.023.
   PubMed Web of Science ®Google Scholar
• Nakai Y, Kogure H, Isayama H, et al. Endoscopic ultrasound-guided biliary drainage for unresectable hilar malignant biliary obstruction. Clin Endosc. 2019;52(3):220–225. doi: 10.5946/ce.2018.094.
   PubMed Web of Science ®Google Scholar
• Sundaram S, Dhir V. EUS-guided biliary drainage for malignant hilar biliary obstruction: a concise review. Endosc Ultrasound. 2021;10(3):154–160. doi: 10.4103/EUS-D-21-00004.
   PubMed Web of Science ®Google Scholar
• Mocan T, Horhat A, Mois E, et al. Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how? World J Gastrointest Oncol. 2021;13(12):2050–2063. doi: 10.4251/wjgo.v13.i12.2050.
   PubMed Web of Science ®Google Scholar
• Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781–1788. doi: 10.1111/j.1572-0241.2007.01279.x.
   PubMed Web of Science ®Google Scholar
• Kakked G, Salameh H, Cheesman AR, et al. Primary EUS-guided biliary drainage versus ERCP drainage for the management of malignant biliary obstruction: a systematic review and meta-analysis. Endosc Ultrasound. 2020;9(5):298–307. doi: 10.4103/eus.eus_10_20.
   PubMed Web of Science ®Google Scholar
• Harvey PR, Baldwin S, Mytton J, et al. Higher volume providers are associated with improved outcomes following ERCP for the palliation of malignant biliary obstruction. EClinicalMedicine. 2020;18:100212. doi: 10.1016/j.eclinm.2019.11.005.
   PubMedGoogle Scholar
• Termsinsuk P, Charatcharoenwitthaya P, Pausawasdi N. Development and validation of a 90-day mortality prediction model following endobiliary drainage in patients with unresectable malignant biliary obstruction. Front Oncol. 2022;12:922386. doi: 10.3389/fonc.2022.922386.
   PubMed Web of Science ®Google Scholar
• Latenstein AEJ, van der Geest LGM, Bonsing BA, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2020;125:83–93. doi: 10.1016/j.ejca.2019.11.002.
   PubMed Web of Science ®Google Scholar
• Izquierdo-Sanchez L, Lamarca A, La Casta A, et al. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA registry. J Hepatol. 2022;76(5):1109–1121. doi: 10.1016/j.jhep.2021.12.010.
   PubMedGoogle Scholar
• Tavakkoli A, Elmunzer BJ, Waljee AK, et al. Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous interventions. Gastrointest Endosc. 2021;93(1):154–162.e5. doi: 10.1016/j.gie.2020.05.061.
   PubMed Web of Science ®Google Scholar